US Patent 8314153 Treatment of pervasive developmental disorders with redox-active therapeutics

Patent 8314153 was granted and assigned to Edison Pharmaceuticals on November, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Edison Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

83141530

Patent Inventor Names

Guy M. Miller0

Viktoria Kheifets0

Date of Patent

November 20, 2012

Patent Application Number

125557000

Date Filed

September 8, 2009

Patent Citations Received

‌

US Patent 11680034 Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

‌

US Patent 11840497 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

‌

US Patent 11938101 Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide

Patent Primary Examiner

‌

Jennifer M Kim

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8314153 Treatment of pervasive developmental disorders with redox-active therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API